Novel influenza vaccine : Calixar patent granted in Europe

October 15, 2019

This patent issued from the fruitful collaboration with the academic laboratory VirPath is a great step forward in the generation of safer and more efficient vaccine candidates.

For licensing opportunities, contact us here

Read the article

Conformational antibody development

Vaccine development

Ligand high-throughput screening

Structure-based drug discovery

Immunoassays

Deorphanization projects

Identification of relevant targets

Expression of full-length membrane proteins

Functional isolation and stabilization of targets

Conformational antibody development

Vaccine development

High-throughput ligand screening

Structure-based drug discovery

Immunoassays

Deorphanization projects

Identification of relevant targets

Expression of full-length membrane proteins

Functional isolation and stabilization of targets

Secure and boost
your discovery programs.

Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.